The H-2B program permits US employers to temporarily hire foreign workers for nonagricultural jobs, with a three-day filing window starting October 1, 2025, and July 3, 2025-26.

COLUMBUS, Ohio — Over the next two years, schools in Ohio will receive $2 billion less in funding, according to the Ohio Education Association. Scott DiMauro, president of the Ohio Education ...

Enterprise AI company Glean announced on Tuesday that it has raised a $150 million Series F led by Wellington Management at a $7.2 billion valuation. This comes less than a year after its $260 ...

Apollo Global Management and Irth Capital Management have approached Papa John's International for a deal that would take the pizza chain private, two people familiar with the matter said Wednesday.

Today, Oregon State second baseman AJ Singer accomplished a career milestone: his first gold glove. The American Baseball Coaches Association (ABCA) named Sing ...

KOMPAS.com - Setelah hampir empat dekade menjadi penanda saat komputer mengalami gangguan sistem, Microsoft akhirnya resmi menyetop tampilan layar "Blue Screen of Death" (BSOD) dari perangkat Windows.

In 2019, NOVA paid Dow $1.08 billion after a 2018 ruling found that NOVA had withheld ethylene output that should have been delivered to Dow. On appeal, the court ordered a recalculation of ...

Di Pilla’s HMC dives after putting $2b renewable dream into review Elouise Fowler Reporter Updated Jul 1, 2025 – 6.29pm, first published at 4.54pm ...

Capital Performance Group conducts the rankings analysis using data provided by S&P Global Market Intelligence. Financial data is based on the Securities and Exchange Commission filings. If SEC data ...

The bill will cut more than $2 billion in taxes but nearly 75% of it will come from eliminating the business rent tax.

The range overlaps with data from Lilly, which reported 8.6% to 12.6% weight loss in a phase 2b trial of orforglipron. MindRank said 70.9% to 85.4% of patients achieved at least 5% weight loss.

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious ...